WASHINGTON — The subpoena comes after Barry Cadden, co-founder of New England Compounding Center, reportedly declined to appear before Congress next week.
BOSTON — Regulators ordered all pharmacists and technicians who worked at the company at the center of the meningitis outbreak to stop working in the drug-compounding industry.
BOSTON — Federal regulators say that further testing has found bacteria in products made by a Framingham pharmacy linked to the deadly fungal meningitis outbreak.
BOSTON — The emergency regulations allow the state to monitor whether the specialty pharmacies are operating more like drug manufacturing facilities.
BOSTON — Lawmakers will hold hearings looking into the Department of Public Health’s handling of the meningitis outbreak and drug lab scandal.
BOSTON — Ameridose is a sister company of New England Compounding Center, the pharmacy at the center of the meningitis outbreak.
BOSTON — The firm sent customers a “report card” touting the cleanliness of its labs, even though internal tests showed widespread contamination.
BOSTON — The Department of Public Health shut down a compounding pharmacy in Waltham after a surprise inspection prompted by the nationwide meningitis outbreak linked to a different company.
BOSTON — The FDA found mold and bacteria in two so-called “clean rooms” in the Framingham specialty pharmacy linked to the nationwide meningitis outbreak.
BOSTON — State officials say they found unclean conditions including visible black particle matter in vials of the recalled injectable steroid.